331 related articles for article (PubMed ID: 24770504)
1. Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients.
Teixeira VB; Cabral R; Brites MM; Vieira R; Figueiredo A
An Bras Dermatol; 2014; 89(2):274-8. PubMed ID: 24770504
[TBL] [Abstract][Full Text] [Related]
2. The association between neurological diseases, malignancies and cardiovascular comorbidities among patients with bullous pemphigoid: Case-control study in a specialized Polish center.
Kalińska-Bienias A; Kowalczyk E; Jagielski P; Bienias P; Kowalewski C; Woźniak K
Adv Clin Exp Med; 2019 May; 28(5):637-642. PubMed ID: 30784240
[TBL] [Abstract][Full Text] [Related]
3. Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study.
Chen YJ; Wu CY; Lin MW; Chen TJ; Liao KK; Chen YC; Hwang CY; Chu SY; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
Br J Dermatol; 2011 Sep; 165(3):593-9. PubMed ID: 21517800
[TBL] [Abstract][Full Text] [Related]
4. Association of bullous pemphigoid and comorbid health conditions: a case-control study.
Lee S; Rastogi S; Hsu DY; Nardone B; Silverberg JI
Arch Dermatol Res; 2021 Jul; 313(5):327-332. PubMed ID: 32647978
[TBL] [Abstract][Full Text] [Related]
5. Bullous pemphigoid and antecedent neurological diseases: An association with dementia.
Yu Phuan CZ; Yew YW; Tey HL
Indian J Dermatol Venereol Leprol; 2017; 83(4):457-461. PubMed ID: 28584223
[TBL] [Abstract][Full Text] [Related]
6. Association between bullous pemphigoid and neurologic diseases: a case-control study.
Casas-de-la-Asunción E; Ruano-Ruiz J; Rodríguez-Martín AM; Vélez García-Nieto A; Moreno-Giménez JC
Actas Dermosifiliogr; 2014 Nov; 105(9):860-5. PubMed ID: 25004905
[TBL] [Abstract][Full Text] [Related]
7. Neurological diseases and bullous pemphigoid: A case-control study in Iranian patients.
Daneshpazhooh M; Khorassani J; Balighi K; Ghandi N; Mahmoudi H; Tohidinik H; Hamzelou S; Chams-Davatchi C
Indian J Dermatol Venereol Leprol; 2017; 83(2):195-199. PubMed ID: 27679408
[TBL] [Abstract][Full Text] [Related]
8. Multimorbidity in bullous pemphigoid: a case-control analysis of bullous pemphigoid patients with age- and gender-matched controls.
Sim B; Fook-Chong S; Phoon YW; Koh HY; Thirumoorthy T; Pang SM; Lee HY
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1709-1714. PubMed ID: 28485892
[TBL] [Abstract][Full Text] [Related]
9. Neurological disorders are associated with bullous pemphigoid.
Papakonstantinou E; Limberg MM; Gehring M; Kotnik N; Kapp A; Gibbs BF; Raap U
J Eur Acad Dermatol Venereol; 2019 May; 33(5):925-929. PubMed ID: 30663128
[TBL] [Abstract][Full Text] [Related]
10. The relationship between neurological disease and bullous pemphigoid: a population-based case-control study.
Langan SM; Groves RW; West J
J Invest Dermatol; 2011 Mar; 131(3):631-6. PubMed ID: 21085189
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical features of Thai patients with bullous pemphigoid.
Kulthanan K; Chularojanamontri L; Tuchinda P; Sirikudta W; Pinkaew S
Asian Pac J Allergy Immunol; 2011 Mar; 29(1):66-72. PubMed ID: 21560490
[TBL] [Abstract][Full Text] [Related]
12. Bullous pemphigoid and neurological disease: statistics from a dermatology service.
Tarazona MJ; Mota AN; Gripp AC; Unterstell N; Bressan AL
An Bras Dermatol; 2015; 90(2):280-2. PubMed ID: 25831008
[TBL] [Abstract][Full Text] [Related]
13. Comorbid diseases among bullous pemphigoid patients in Germany: new insights from a case-control study.
Martin E; Mauer I; Malzahn U; Heuschmann PU; Goebeler M; Benoit S
J Dtsch Dermatol Ges; 2022 Jun; 20(6):798-805. PubMed ID: 35657083
[TBL] [Abstract][Full Text] [Related]
14. Bullous pemphigoid in a leg affected with hemiparesia: a possible relation of neurological diseases with bullous pemphigoid?
Foureur N; Descamps V; Lebrun-Vignes B; Picard-Dahan C; Grossin M; Belaich S; Crickx B
Eur J Dermatol; 2001; 11(3):230-3. PubMed ID: 11358730
[TBL] [Abstract][Full Text] [Related]
15. Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland.
Benzaquen M; Borradori L; Berbis P; Cazzaniga S; Valero R; Richard MA; Feldmeyer L
J Am Acad Dermatol; 2018 Jun; 78(6):1090-1096. PubMed ID: 29274348
[TBL] [Abstract][Full Text] [Related]
16. Comorbidity in bullous pemphigoid: up-date and clinical implications.
Huttelmaier J; Benoit S; Goebeler M
Front Immunol; 2023; 14():1196999. PubMed ID: 37457698
[TBL] [Abstract][Full Text] [Related]
17. A population-based study of the association between bullous pemphigoid and neurologic disorders.
Brick KE; Weaver CH; Savica R; Lohse CM; Pittelkow MR; Boeve BF; Gibson LE; Camilleri MJ; Wieland CN
J Am Acad Dermatol; 2014 Dec; 71(6):1191-7. PubMed ID: 25174542
[TBL] [Abstract][Full Text] [Related]
18. A History of Asthma Increases the Risk of Bullous Pemphigoid: Insights from a Large Population-Based Study.
Kridin K; Ludwig RJ; Tzur Bitan D; Cohen AD
Dermatology; 2021; 237(6):921-928. PubMed ID: 33640889
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for the Development of Bullous Pemphigoid in US Patients Receiving Immune Checkpoint Inhibitors.
Said JT; Liu M; Talia J; Singer SB; Semenov YR; Wei EX; Mostaghimi A; Nelson CA; Giobbie-Hurder A; LeBoeuf NR
JAMA Dermatol; 2022 May; 158(5):552-557. PubMed ID: 35416925
[TBL] [Abstract][Full Text] [Related]
20. Association between inflammatory bowel disease and bullous pemphigoid: a population-based case-control study.
Chen YJ; Juan CK; Chang YT; Wu CY; Ho HJ; Tseng HC
Sci Rep; 2020 Jul; 10(1):12727. PubMed ID: 32728039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
